1-[4-(4-methoxyanilino)pyrimidin-2-yl]-N-[[4-(trifluoromethyl)phenyl]methyl]piperidine-3-carboxamide
C25H26F3N5O2 — CID 134800087
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(4-methoxyanilino)pyrimidin-2-yl]-N-[[4-(trifluoromethyl)phenyl]methyl]piperidine-3-carboxamide
1-[4-(4-methoxyanilino)pyrimidin-2-yl]-N-[[4-(trifluoromethyl)phenyl]methyl]piperidine-3-carboxamide (PubChem CID 134800087) has the molecular formula C25H26F3N5O2 and a molecular weight of 485.51 g/mol. Its IUPAC name is 1-[4-(4-methoxyanilino)pyrimidin-2-yl]-N-[[4-(trifluoromethyl)phenyl]methyl]piperidine-3-carboxamide.
Molecular Properties
| Compound Name | 1-[4-(4-methoxyanilino)pyrimidin-2-yl]-N-[[4-(trifluoromethyl)phenyl]methyl]piperidine-3-carboxamide |
|---|---|
| PubChem CID | 134800087 |
| Molecular Formula | C25H26F3N5O2 |
| Molecular Weight | 485.51 g/mol |
| Exact Mass | 485.20 |
| IUPAC Name | 1-[4-(4-methoxyanilino)pyrimidin-2-yl]-N-[[4-(trifluoromethyl)phenyl]methyl]piperidine-3-carboxamide |
| SMILES | COc1ccc(Nc2ccnc(N3CCCC(C(=O)NCc4ccc(C(F)(F)F)cc4)C3)n2)cc1 |
| InChI | InChI=1S/C25H26F3N5O2/c1-35-21-10-8-20(9-11-21)31-22-12-13-29-24(32-22)33-14-2-3-18(16-33)23(34)30-15-17-4-6-19(7-5-17)25(26,27)28/h4-13,18H,2-3,14-16H2,1H3,(H,30,34)(H,29,31,32) |
| InChIKey | FLNSUOVGPNJRMP-UHFFFAOYSA-N |
| XLogP | 4.78 |
| TPSA | 79.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 485.51 |
| LogP ≤ 5 | 4.78 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134800087 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.